EP1071765A4 - Reactions de alk-1 au tgf-beta et des signaux traversant smad-1 et smad-5 - Google Patents

Reactions de alk-1 au tgf-beta et des signaux traversant smad-1 et smad-5

Info

Publication number
EP1071765A4
EP1071765A4 EP99912583A EP99912583A EP1071765A4 EP 1071765 A4 EP1071765 A4 EP 1071765A4 EP 99912583 A EP99912583 A EP 99912583A EP 99912583 A EP99912583 A EP 99912583A EP 1071765 A4 EP1071765 A4 EP 1071765A4
Authority
EP
European Patent Office
Prior art keywords
smad
alk
tgf
responds
beta
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99912583A
Other languages
German (de)
English (en)
Other versions
EP1071765A1 (fr
Inventor
Kohei Miyazono
Takeshe Imamura
Dijke Peter Ten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Original Assignee
Ludwig Institute for Cancer Research Ltd
Ludwig Institute for Cancer Research New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Institute for Cancer Research Ltd, Ludwig Institute for Cancer Research New York filed Critical Ludwig Institute for Cancer Research Ltd
Priority to EP09156929A priority Critical patent/EP2078752A3/fr
Publication of EP1071765A1 publication Critical patent/EP1071765A1/fr
Publication of EP1071765A4 publication Critical patent/EP1071765A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99912583A 1998-03-13 1999-03-12 Reactions de alk-1 au tgf-beta et des signaux traversant smad-1 et smad-5 Withdrawn EP1071765A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP09156929A EP2078752A3 (fr) 1998-03-13 1999-03-12 Réactions de ALK-1 au TGF-beta et des signaux traversant SMAD-1 et SMAD-5

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3917798A 1998-03-13 1998-03-13
US39177 1998-03-13
PCT/US1999/005735 WO1999046386A1 (fr) 1998-03-13 1999-03-12 REACTIONS DE ALK-1 AU TGF-β ET DES SIGNAUX TRAVERSANT SMAD-1 ET SMAD-5

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP09156929A Division EP2078752A3 (fr) 1998-03-13 1999-03-12 Réactions de ALK-1 au TGF-beta et des signaux traversant SMAD-1 et SMAD-5

Publications (2)

Publication Number Publication Date
EP1071765A1 EP1071765A1 (fr) 2001-01-31
EP1071765A4 true EP1071765A4 (fr) 2003-01-15

Family

ID=21904084

Family Applications (2)

Application Number Title Priority Date Filing Date
EP99912583A Withdrawn EP1071765A4 (fr) 1998-03-13 1999-03-12 Reactions de alk-1 au tgf-beta et des signaux traversant smad-1 et smad-5
EP09156929A Withdrawn EP2078752A3 (fr) 1998-03-13 1999-03-12 Réactions de ALK-1 au TGF-beta et des signaux traversant SMAD-1 et SMAD-5

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP09156929A Withdrawn EP2078752A3 (fr) 1998-03-13 1999-03-12 Réactions de ALK-1 au TGF-beta et des signaux traversant SMAD-1 et SMAD-5

Country Status (3)

Country Link
EP (2) EP1071765A4 (fr)
AU (1) AU3092899A (fr)
WO (1) WO1999046386A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ502058A (en) * 1999-12-23 2003-11-28 Ovita Ltd Isolated mutated nucleic acid molecule for regulation of ovulation rate
PT2447283E (pt) * 2005-09-07 2015-10-08 Pfizer Anticorpos monoclonais humanos para cinase-1 tipo recetor de activina (alk-1)
US8642031B2 (en) 2006-11-02 2014-02-04 Acceleron Pharma, Inc. Antagonists of BMP9, BMP10, ALK1 and other ALK1 ligands, and uses thereof
MX2009004718A (es) 2006-11-02 2009-06-19 Acceleron Pharma Inc Antagonistas de receptor de alk1 y ligando y sus usos.
US10059756B2 (en) 2006-11-02 2018-08-28 Acceleron Pharma Inc. Compositions comprising ALK1-ECD protein
WO2008128559A1 (fr) * 2007-04-20 2008-10-30 Stichting Katholieke Universiteit Procédé de production d'un composé capable d'interférer avec un phénotype déformé de chondrocytes
KR20180029111A (ko) 2008-05-02 2018-03-19 악셀레론 파마 인코포레이티드 혈관신생 및 혈관주위세포 적용범위의 조정을 위한 ａｌｋ１ 길항제 기재의 방법 및 조성물

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007135A2 (fr) * 1995-08-14 1997-02-27 Creative Biomolecules, Inc. Liaison de la proteine oestrogene 1 (op-1) et de ses analogues avec le recepteur alk-1 de surface de cellule et ses analogues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE234920T1 (de) * 1992-11-17 2003-04-15 Ludwig Inst Cancer Res Aktivin-rezeptor-ähnliche kinasen, proteine mit serin/threonin kinase domänen und deren anwendungen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997007135A2 (fr) * 1995-08-14 1997-02-27 Creative Biomolecules, Inc. Liaison de la proteine oestrogene 1 (op-1) et de ses analogues avec le recepteur alk-1 de surface de cellule et ses analogues

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
ATTISANO L ET AL: "IDENTIFICATION OF HUMAN ACTIVIN AND TGFBETA TYPE I RECEPTORS THAT FORM HETEROMERIC KINASE COMPLEXES WITH TYPE II RECEPTORS", CELL, CELL PRESS, CAMBRIDGE, NA, US, vol. 75, 19 November 1993 (1993-11-19), pages 671 - 680, XP000611962, ISSN: 0092-8674 *
DIJKE TEN P ET AL: "CHARACTERIZATION OF TYPE I RECEPTORS FOR TRANSFORMING GROWTH FACTOR-B AND ACTIVIN", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 264, no. 5155, 1 April 1994 (1994-04-01), pages 101 - 104, XP000561968, ISSN: 0036-8075 *
FENG X H ET AL: "A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.", THE EMBO JOURNAL. ENGLAND 1 JUL 1997, vol. 16, no. 13, 1 July 1997 (1997-07-01), pages 3912 - 3923, XP002219537, ISSN: 0261-4189 *
KRETZSCHMAR M ET AL: "SMADS: MEDIATORS AND REGULATORS OF TGF-BETA SIGNALING", CURRENT OPINION IN GENETICS & DEVELOPMENT, CURRENT BIOLOGY LTD, XX, vol. 8, no. 8, February 1998 (1998-02-01), pages 103 - 111, XP000857433, ISSN: 0959-437X *
KRETZSCHMAR M ET AL: "THE TGF-BETA FAMILY MEDIATOR SMAD1 IS PHOSPHORYLATED DIRECTLY AND ACTIVATED FUNCTIONALLY BY THE BMP RECEPTOR KINASE", GENES AND DEVELOPMENT, COLD SPRING HARBOR, NY, US, vol. 11, no. 8, 15 April 1997 (1997-04-15), pages 984 - 995, XP002911614, ISSN: 0890-9369 *
LECHLEIDER R J ET AL: "SERINE PHOSPHORYLATION, CHROMOSOMAL LOCALIZATION, AND TRANSFORMING GROWTH FACTOR-BETA SIGNAL TRANSDUCTION BY HUMAN BSP-1", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 271, no. 30, 26 July 1996 (1996-07-26), pages 17617 - 17620, XP002030329, ISSN: 0021-9258 *
PERSSON U ET AL: "TRANSFORMING GROWTH FACTOR (TGF-BETA)-SPECIFIC SIGNALING BY CHIMERIC TGF-BETA TYPE II RECEPTOR WITH INTRACELLULAR DOMAIN OF ACTIVIN TYPE IIB RECEPTOR", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 272, no. 34, 22 August 1997 (1997-08-22), pages 21187 - 21194, XP002934435, ISSN: 0021-9258 *
See also references of WO9946386A1 *
TAKASE M ET AL: "Induction of Smad6 mRNA by bone morphogenetic proteins.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. UNITED STATES 6 MAR 1998, vol. 244, no. 1, 6 March 1998 (1998-03-06), pages 26 - 29, XP002219536, ISSN: 0006-291X *
YINGLING J M ET AL: "Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. UNITED STATES 20 AUG 1996, vol. 93, no. 17, 20 August 1996 (1996-08-20), pages 8940 - 8944, XP002219535, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO1999046386B1 (fr) 1999-10-21
EP2078752A2 (fr) 2009-07-15
AU3092899A (en) 1999-09-27
EP1071765A1 (fr) 2001-01-31
EP2078752A3 (fr) 2009-09-23
WO1999046386A1 (fr) 1999-09-16

Similar Documents

Publication Publication Date Title
HUP0004048A2 (en) Faecal collector
GB0004544D0 (en) Polymers their preparation and uses
AU2168597A (en) Improvements in or relating to encapsulation
IL120016A0 (en) Heteroatom-containing cyclopentanopyridyl-oxazolidinones their preparation and use
GB9607804D0 (en) Anemometer
AUPP744198A0 (en) Surfboards and improvements to surfboards
EP1071765A4 (fr) Reactions de alk-1 au tgf-beta et des signaux traversant smad-1 et smad-5
HK1031824A1 (en) Parenteral formulations comprising 10-hydroxy-10, 11-tetrahydrocarbamazepine, water and glucose
IL120904A (en) 1-c-perfluororoalkyl monosaccharides and their preparation
PL328334A1 (en) Preparation and application thereof
IL130700A0 (en) Cyanophosphorus compounds and their preparation
AUPO848197A0 (en) Breast screening - early detection and aid to diagnosis
GB2310319B (en) Improvements in or relating to antennas
GB9720285D0 (en) Improvements in or relating to phasing receivers
AU4843197A (en) Improvement in or relating to netting
GB9820865D0 (en) Improvements relating to water-bourne vessels
HUP9902379A2 (en) Firering and dust-separator apparatous to utilize plant-wastes by air-protecting way
EP1066051A4 (fr) Scielline et utilisations de celle-ci
GB9904033D0 (en) Improvements to bowsers
GB9706277D0 (en) Improvements in or relating to construction sets
GB9810380D0 (en) Improved power and signals
HK1038687A1 (en) Antibodies to truncated vegf-d and uses thereof
GB9619202D0 (en) Improvements to subsills
GB9601057D0 (en) Improvements to rotorcraf
AUPN841996A0 (en) Water netball

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000925

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20021203

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20040716

17Q First examination report despatched

Effective date: 20040716

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1032245

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20090420